Form D Explorer

Abingworth Clinical Co-Development Fund 3 LP research brief

CIK 2049495

Generated Nov. 17, 2026, 4:54 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: WASHINGTON District of Columbia. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

Reviewed offering links

Citation: Form D Explorer, “Abingworth Clinical Co-Development Fund 3 LP research brief,” CIK 2049495, retrieved Nov. 17, 2026, 4:54 p.m.. Cite the specific accessions used. No amounts have been summed.